Oregon Health & Science 8th Annual MS and CNS Neuroimmunology Symposium 2025

This accredited half-day symposium provides health care professionals information to identify, refer, treat and/or implement practice changes to improve the care of patients with neuroimmunological disorders. Specific disorders discussed this year include a 2 part update on Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy, stopping therapy in MS, Transverse myelitis, Anti-Amyloid Therapies, and managing fatigue.

Who should attend

Neurologists, neuroimmunologists, rheumatologists, ophthalmologists, neurosurgeons, physicians, nurse practitioners, rehabilitation including physical and occupational therapists, researchers, and other medical professionals in the field of neuroimmunological disorders are invited to attend.

Learning objectives

In Oregon Health & Science 8th Annual MS and CNS Neuroimmunology Symposium 2025 you will learn:

• Identify current diagnostic criteria and treatment updates for myasthenia gravis
• Recognize clinical features and apply updated management strategies for chronic inflammatory demyelinating polyneuropathy (CIDP)
• Evaluate appropriate criteria and timing for discontinuing disease-modifying therapies in multiple sclerosis patients
• Analyze case-based presentations of transverse myelitis to improve diagnostic accuracy and treatment decision-making
• Implement evidence-based strategies for managing fatigue in patients with multiple sclerosis
• Assess patient eligibility and monitoring requirements for anti-amyloid therapies in early-stage Alzheimer’s disease